Live Analyst Rating Changes 26423 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Tessa Romero
JPM

Tessa Romero

J.P. Morgan
Wall Street Analyst
★★★★☆
#711
on 13Foresight · ranked by our own returns
60%
Success Rate
+4.5%
Average Return
26 of 43 calls profitable · +52.3% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 60% of Tessa Romero's ratings turned a profit when each position was held for 2 year — averaging +4.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

64 Buy 15 Hold 5 Sell
Tessa's Stock Coverage 23 ratings · 2026-08-21
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
CYTK
Cytokinetics
 Aug 20, 2026 BUY Strong Buy
+17.0% avg upside
36 analysts
 — · ·
EWTX
Edgewise Therapeutics
 Aug 20, 2026 BUY Strong Buy
+4.8% avg upside
15 analysts
$60.00
38.54% Upside
 +1.0% ·
SEPN
Septerna, Inc.
 Aug 19, 2026 BUY Strong Buy
+26.2% avg upside
12 analysts
$48.00
17.73% Upside
 +0.0% ·
EYPT
EyePoint Pharmaceuticals
 Aug 17, 2026 HOLD Strong Buy
+330.0% avg upside
21 analysts
 — +12.3% ·
UPB
Upstream Bio, Inc.
 Aug 14, 2026 HOLD Strong Buy
+374.1% avg upside
9 analysts
$9.00
31.45% Upside
 +0.0% ·
OCS
Oculis Holding
 Aug 14, 2026 BUY Strong Buy
+183.4% avg upside
11 analysts
$20.00
52.20% Upside
 +1.1% ·
SRRK
Scholar Rock Holding
 Aug 13, 2026 BUY Strong Buy
+4.5% avg upside
23 analysts
$63.00
13.97% Upside
 +3.1% ·
XENE
Xenon
 Aug 11, 2026 BUY Strong Buy
+4.2% avg upside
28 analysts
$82.00
37.29% Upside
 -0.1% ·
DYN
Dyne Therapeutics
 Jul 30, 2026 HOLD Strong Buy
+53.4% avg upside
31 analysts
 — +1.6% ·
BHVN
Biohaven Ltd.
 Jun 30, 2026 BUY Strong Buy
+69.1% avg upside
25 analysts
 — -1.6% ·
LRMR
Larimar Therapeutics
 Jun 29, 2026 BUY Strong Buy
+327.1% avg upside
22 analysts
$9.00
116.29% Upside
 +36.2% ·
LXEO
Lexeo Therapeutics, Inc.
 Jun 25, 2026 BUY Strong Buy
+282.7% avg upside
11 analysts
$9.00
77.81% Upside
 +7.7% ·
AGIO
Agios Pharma
 Jun 11, 2026 HOLD Strong Buy
+84.1% avg upside
29 analysts
$31.00
7.81% Downside
 +16.9% ·
NRIX
Nurix Therapeutics
 Jun 11, 2026 BUY Strong Buy
+19.4% avg upside
28 analysts
 — +60.0% ·
SPTX
Seaport Therapeutics, Inc.
 Jun 08, 2026 BUY Strong Buy
+59.8% avg upside
6 analysts
$42.00
74.75% Upside
 +49.5% ·
NMRA
Neumora Therapeutics, Inc.
 May 26, 2026 SELL Buy
+404.1% avg upside
11 analysts
 — +13.0% ·
RCKT
Rocket Pharmaceuticals
 Apr 02, 2026 SELL Buy
+378.2% avg upside
29 analysts
 — +2.2% ·
ACAD
ACADIA Pharmaceuticals
 Mar 04, 2026 BUY Strong Buy
+26.4% avg upside
43 analysts
$34.00
17.00% Upside
 +29.2% ·
PRME
Prime Medicine, Inc.
 Nov 18, 2025 HOLD Strong Buy
+199.6% avg upside
16 analysts
 — -13.0% ·
MCRB
Seres Therapeutics
 Oct 23, 2024 SELL Buy
+263.9% avg upside
11 analysts
 — +70.0% ·
SANA
Sana Biotechnology
 Oct 18, 2024 HOLD Strong Buy
+162.5% avg upside
14 analysts
 — -16.1% ·
ATRA
Atara Biotherapeutics
 Jul 13, 2022 HOLD Buy
+92.2% avg upside
18 analysts
$10.00
6.55% Upside
 -89.2% ·
RIGL
Rigel
 Nov 09, 2020 HOLD Strong Buy
-40.8% avg upside
17 analysts
 — -74.3% ·
🔒 18 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Tessa Romero — Frequently Asked Questions
How accurate are Tessa Romero's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Tessa's ratings were profitable over a one-year hold, with an average return of +6.7% per rating, or +49.2% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Tessa ranked on 13Foresight?
Tessa Romero is currently ranked #711 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Tessa cover?
Tessa most recently has ratings on CYTK, EWTX, SEPN, EYPT, UPB, OCS, SRRK, XENE, DYN, BHVN, LRMR, LXEO and 11 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.